Upstream Bio, Inc.
UPB
$6.75
$0.396.13%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -40.59M | -42.46M | -33.75M | -39.97M | -27.27M |
| Total Depreciation and Amortization | 49.00K | 57.00K | 46.00K | 42.00K | 43.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.04M | 4.02M | 2.58M | 1.75M | 1.03M |
| Change in Net Operating Assets | -11.35M | 7.75M | 8.88M | -1.07M | -14.97M |
| Cash from Operations | -47.85M | -30.63M | -22.24M | -39.24M | -41.17M |
| Capital Expenditure | -- | -54.00K | -64.00K | -47.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 42.40M | 59.00M | 48.25M | 12.82M | -213.38M |
| Cash from Investing | 42.40M | 58.94M | 48.19M | 12.77M | -213.38M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 598.00K | 1.10M | 760.00K | 612.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | -34.00K |
| Cash from Financing | 598.00K | 1.10M | 760.00K | 612.00K | -34.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.85M | 29.41M | 26.71M | -25.85M | -254.58M |